Survivorship in Lynch Syndrome Families
Status: | Active, not recruiting |
---|---|
Conditions: | Colorectal Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 10/13/2018 |
Start Date: | June 20, 2010 |
End Date: | June 2019 |
Cancer Survivorship in Lynch Syndrome: Impact on Patients and Families
Objectives:
Specific Aims:
1. Researchers will evaluate and compare predictors of health-related quality of life (QOL)
among colorectal cancer (CRC) survivors who have Lynch syndrome (LS) with those patients
who have sporadic CRC using both quantitative and qualitative methodology.
a. In both CRC groups, researchers will evaluate cancer preventive and health behaviors,
including lifestyle factors and screening, psychosocial factors, including mood, family
functioning, coping style, anxiety, depression, and social resources, and health care
system factors, including interactions with health care providers and service
utilization.
2. Researchers will compare the experience of first-degree relatives (FDRs) of patients who
have LS with that of FDRs of patients who have sporadic CRC using both quantitative and
qualitative methodology.
a. Researchers will evaluate all of the domains listed above, as well as anticipatory
grief, assessment of caregiving responsibilities, and fear of cancer in FDRs of patients
with LS-related and sporadic CRC.
3. Researchers will examine CRC patients from both groups and their FDRs using dyadic
analyses in order to evaluate the similarities and differences in their survivorship
experience.
4. Researchers will evaluate the preventive and health behavior of patients who are
non-conclusive for Lynch syndrome and their family members. They will examine their
screening behavior and will explore how the interaction between the patients and their
relatives affects the relatives' screening behavior. They also will examine how these
non conclusive LS patients and their family members perceive their risk for LS-related
cancers.
Specific Aims:
1. Researchers will evaluate and compare predictors of health-related quality of life (QOL)
among colorectal cancer (CRC) survivors who have Lynch syndrome (LS) with those patients
who have sporadic CRC using both quantitative and qualitative methodology.
a. In both CRC groups, researchers will evaluate cancer preventive and health behaviors,
including lifestyle factors and screening, psychosocial factors, including mood, family
functioning, coping style, anxiety, depression, and social resources, and health care
system factors, including interactions with health care providers and service
utilization.
2. Researchers will compare the experience of first-degree relatives (FDRs) of patients who
have LS with that of FDRs of patients who have sporadic CRC using both quantitative and
qualitative methodology.
a. Researchers will evaluate all of the domains listed above, as well as anticipatory
grief, assessment of caregiving responsibilities, and fear of cancer in FDRs of patients
with LS-related and sporadic CRC.
3. Researchers will examine CRC patients from both groups and their FDRs using dyadic
analyses in order to evaluate the similarities and differences in their survivorship
experience.
4. Researchers will evaluate the preventive and health behavior of patients who are
non-conclusive for Lynch syndrome and their family members. They will examine their
screening behavior and will explore how the interaction between the patients and their
relatives affects the relatives' screening behavior. They also will examine how these
non conclusive LS patients and their family members perceive their risk for LS-related
cancers.
Data will be collected primarily using a mailed self-administered questionnaire. A subset of
the participants who complete the mailed questionnaire will be recontacted and invited to
participate in an in-depth, semi-structured telephone interview.
Qualitative Mailed Questionnaires:
Participants will complete a questionnaire that contains questions about your experiences
living with colorectal cancer. The questionnaire should take 45-60 minutes to complete.
Up to 200 colorectal cancer survivors and up to 200 close relatives of colorectal cancer
survivors will take part in this portion of the study.
Telephone Interviews:
In the phone interview, you will be asked some questions about your experiences living with
colorectal cancer. The phone interview should take 30-45 minutes to complete.
Up to 30 colorectal cancer survivors and up to 30 close relatives of colorectal cancer
survivors will take part in this portion of the study.
the participants who complete the mailed questionnaire will be recontacted and invited to
participate in an in-depth, semi-structured telephone interview.
Qualitative Mailed Questionnaires:
Participants will complete a questionnaire that contains questions about your experiences
living with colorectal cancer. The questionnaire should take 45-60 minutes to complete.
Up to 200 colorectal cancer survivors and up to 200 close relatives of colorectal cancer
survivors will take part in this portion of the study.
Telephone Interviews:
In the phone interview, you will be asked some questions about your experiences living with
colorectal cancer. The phone interview should take 30-45 minutes to complete.
Up to 30 colorectal cancer survivors and up to 30 close relatives of colorectal cancer
survivors will take part in this portion of the study.
Inclusion Criteria:
1. Colorectal cancer (CRC) patients with Lynch-syndrome related CRC: Diagnosis of CRC
2. Colorectal cancer (CRC) patients with sporadic CRC: Diagnosis of CRC
3. All First-degree relatives (FDRs): Siblings or adult children of recruited CRC
patients
4. All Participants: 18 years of age or older
5. All Participants: Able to read and speak English
6. All Participants: Able to be contacted by mail.
7. All Second and Third relatives (SDRs and TDRs): Grandparents, grandchildren, aunts,
uncles, nieces, nephews, and first-degree cousins of recruited CRC patients
8. IPs with a LS MMR mutation who were seen at MDACC for genetic counseling and testing
during 2011-2014.
Exclusion Criteria:
1) CRC patients with sporadic CRC: Personal or family history of Lynch syndrome, familial
adenomatous polyposis, inflammatory bowel disease or those who have a FDR with CRC
We found this trial at
1
site
1515 Holcombe Blvd
Houston, Texas 77030
Houston, Texas 77030
713-792-2121
Principal Investigator: Susan Peterson, PHD, MPH
University of Texas M.D. Anderson Cancer Center The mission of The University of Texas MD...
Click here to add this to my saved trials